Algert Global LLC Buys 109,870 Shares of STAAR Surgical (NASDAQ:STAA)

Algert Global LLC grew its position in shares of STAAR Surgical (NASDAQ:STAA - Free Report) by 134.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 191,398 shares of the medical instruments supplier's stock after purchasing an additional 109,870 shares during the quarter. Algert Global LLC owned approximately 0.39% of STAAR Surgical worth $4,649,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of STAA. MetLife Investment Management LLC raised its holdings in STAAR Surgical by 6.3% in the 4th quarter. MetLife Investment Management LLC now owns 30,396 shares of the medical instruments supplier's stock worth $738,000 after purchasing an additional 1,796 shares during the period. Illinois Municipal Retirement Fund grew its stake in STAAR Surgical by 8.3% in the 4th quarter. Illinois Municipal Retirement Fund now owns 30,144 shares of the medical instruments supplier's stock valued at $732,000 after acquiring an additional 2,318 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in STAAR Surgical by 9.4% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 35,613 shares of the medical instruments supplier's stock worth $866,000 after acquiring an additional 3,066 shares in the last quarter. Generali Investments Towarzystwo Funduszy Inwestycyjnych lifted its holdings in STAAR Surgical by 9.7% during the fourth quarter. Generali Investments Towarzystwo Funduszy Inwestycyjnych now owns 39,500 shares of the medical instruments supplier's stock valued at $959,000 after purchasing an additional 3,500 shares in the last quarter. Finally, Nebula Research & Development LLC grew its position in shares of STAAR Surgical by 19.0% in the fourth quarter. Nebula Research & Development LLC now owns 23,210 shares of the medical instruments supplier's stock valued at $564,000 after purchasing an additional 3,700 shares during the period. Institutional investors and hedge funds own 96.70% of the company's stock.

STAAR Surgical Stock Performance

Shares of STAA stock traded down $0.17 during mid-day trading on Friday, hitting $19.36. 970,771 shares of the stock traded hands, compared to its average volume of 808,612. STAAR Surgical has a twelve month low of $13.50 and a twelve month high of $49.86. The company's 50-day simple moving average is $17.57 and its 200-day simple moving average is $21.92. The firm has a market cap of $958.82 million, a price-to-earnings ratio of -47.22 and a beta of 0.65.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on STAA. StockNews.com cut shares of STAAR Surgical from a "hold" rating to a "sell" rating in a research note on Thursday, February 13th. Jefferies Financial Group downgraded STAAR Surgical from a "buy" rating to a "hold" rating in a research note on Wednesday, February 12th. Mizuho cut shares of STAAR Surgical from an "outperform" rating to a "neutral" rating and cut their price objective for the stock from $45.00 to $17.00 in a research report on Wednesday, February 12th. Stifel Nicolaus cut their price target on shares of STAAR Surgical from $38.00 to $20.00 and set a "buy" rating for the company in a report on Wednesday, February 12th. Finally, BTIG Research cut STAAR Surgical from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 12th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $24.63.

Insider Buying and Selling at STAAR Surgical

In other STAAR Surgical news, major shareholder Broadwood Partners, L.P. acquired 497,631 shares of the business's stock in a transaction that occurred on Friday, April 4th. The shares were purchased at an average price of $15.91 per share, with a total value of $7,917,309.21. Following the completion of the transaction, the insider now owns 13,194,210 shares in the company, valued at $209,919,881.10. The trade was a 3.92 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Over the last ninety days, insiders bought 1,742,581 shares of company stock valued at $28,407,543. 1.00% of the stock is currently owned by corporate insiders.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.